• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

卵巢癌中的 microRNAs。

MicroRNAs in ovarian carcinomas.

机构信息

Laboratory of Cellular and Molecular Biology, National Institute on Aging, NIH Biomedical Research Center, 251 Bayview Boulevard, Suite 100, Baltimore, Maryland 21224, USA.

出版信息

Endocr Relat Cancer. 2010 Jan 29;17(1):F77-89. doi: 10.1677/ERC-09-0203. Print 2010 Mar.

DOI:10.1677/ERC-09-0203
PMID:19903743
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC2856347/
Abstract

The molecular mechanisms involved in epithelial ovarian cancer initiation and progression are just beginning to be elucidated. In particular, it has become evident that microRNAs (miRNAs or miRs), a class of molecules that post-transcriptionally regulate gene expression, play a major role in ovarian tumorigenesis. Several microRNA profiling studies have identified changes in microRNA patterns that take place during ovarian cancer development. While most deregulated microRNAs are down-regulated in cancer, and may therefore act as tumor suppressors, others are elevated and may represent novel oncogenes in this disease. A number of microRNAs identified as aberrantly expressed in ovarian carcinoma have been shown to have important functional roles in cancer development and may therefore represent targets for therapy. In addition, some of the microRNA patterns may have prognostic significance. The identification of functional targets represents a major hurdle in our understanding of microRNA function in ovarian carcinoma, but significant progress is being made. It is hoped that a better understanding of the microRNA expression and roles in ovarian cancer may provide new avenues for the detection, diagnosis, and therapy of this deadly disease.

摘要

上皮性卵巢癌发生和进展中涉及的分子机制才刚刚开始被阐明。特别是,microRNAs(miRNAs 或 miRs),一类在后转录水平上调节基因表达的分子,在卵巢肿瘤发生中起主要作用,这一点已变得明显。几项 microRNA 谱分析研究已经确定了在卵巢癌发展过程中发生的 microRNA 模式变化。虽然大多数失调的 microRNAs在癌症中下调,因此可能作为肿瘤抑制因子发挥作用,但其他 microRNAs上调,可能在这种疾病中代表新的癌基因。已经证明,在卵巢癌中异常表达的许多 microRNAs在癌症发展中具有重要的功能作用,因此可能代表治疗的靶点。此外,一些 microRNA 模式可能具有预后意义。确定功能靶点是我们理解 microRNA 在卵巢癌中功能的主要障碍,但正在取得重大进展。希望更好地了解 microRNA 在卵巢癌中的表达和作用可能为这种致命疾病的检测、诊断和治疗提供新途径。

相似文献

1
MicroRNAs in ovarian carcinomas.卵巢癌中的 microRNAs。
Endocr Relat Cancer. 2010 Jan 29;17(1):F77-89. doi: 10.1677/ERC-09-0203. Print 2010 Mar.
2
The hypoxia-related microRNA miR-199a-3p displays tumor suppressor functions in ovarian carcinoma.缺氧相关的微小RNA miR-199a-3p在卵巢癌中发挥肿瘤抑制功能。
Oncotarget. 2015 May 10;6(13):11342-56. doi: 10.18632/oncotarget.3604.
3
Deregulation of microRNA expression in follicular-cell-derived human thyroid carcinomas.滤泡细胞源性人甲状腺癌中 microRNA 表达的失调。
Endocr Relat Cancer. 2010 Jan 29;17(1):F91-104. doi: 10.1677/ERC-09-0217. Print 2010 Mar.
4
Analysis of microarray-identified genes and microRNAs associated with drug resistance in ovarian cancer.与卵巢癌耐药相关的微阵列鉴定基因和微小RNA的分析。
Int J Clin Exp Pathol. 2015 Jun 1;8(6):6847-58. eCollection 2015.
5
miR-494 suppresses tumor growth of epithelial ovarian carcinoma by targeting IGF1R.微小RNA-494通过靶向胰岛素样生长因子1受体抑制上皮性卵巢癌的肿瘤生长。
Tumour Biol. 2016 Jun;37(6):7767-76. doi: 10.1007/s13277-015-4603-8. Epub 2015 Dec 22.
6
miR-509-3p enhances platinum drug sensitivity in ovarian cancer.miR-509-3p 增强卵巢癌细胞对铂类药物的敏感性。
Gene. 2019 Feb 20;686:63-67. doi: 10.1016/j.gene.2018.11.011. Epub 2018 Nov 5.
7
Identification of genes and microRNAs involved in ovarian carcinogenesis.参与卵巢癌发生的基因和微小RNA的鉴定。
Asian Pac J Cancer Prev. 2012;13(8):3997-4000. doi: 10.7314/apjcp.2012.13.8.3997.
8
Epigenetic regulation of CD133 and tumorigenicity of CD133+ ovarian cancer cells.CD133的表观遗传调控与CD133+卵巢癌细胞的致瘤性
Oncogene. 2009 Jan 15;28(2):209-18. doi: 10.1038/onc.2008.374. Epub 2008 Oct 6.
9
The Role of MicroRNAs in Lung Cancer: Implications for Diagnosis and Therapy.微小 RNA 在肺癌中的作用:对诊断和治疗的启示。
Curr Mol Med. 2020;20(2):90-101. doi: 10.2174/1566524019666191001113511.
10
MicroRNA expression and identification of putative miRNA targets in ovarian cancer.卵巢癌中MicroRNA表达及潜在miRNA靶标的鉴定
PLoS One. 2008 Jun 18;3(6):e2436. doi: 10.1371/journal.pone.0002436.

引用本文的文献

1
Long Non-Coding, Micro, and Circular RNAs in Ovarian Cancer Metastasis: Pathways and Treatment Approaches.长链非编码RNA、微小RNA和环状RNA在卵巢癌转移中的作用:途径与治疗方法
Reprod Sci. 2025 Aug 15. doi: 10.1007/s43032-025-01948-x.
2
The role of Lin28A and Lin28B in cancer beyond Let-7.Lin28A和Lin28B在癌症中除Let-7之外的作用。
FEBS Lett. 2024 Dec;598(24):2963-2979. doi: 10.1002/1873-3468.15004. Epub 2024 Aug 16.
3
microRNA-184 in the landscape of human malignancies: a review to roles and clinical significance.人类恶性肿瘤中的 microRNA-184:作用与临床意义综述
Cell Death Discov. 2023 Nov 24;9(1):423. doi: 10.1038/s41420-023-01718-1.
4
MicroRNA targeting: A novel therapeutic intervention for ovarian cancer.微小RNA靶向作用:卵巢癌的一种新型治疗干预手段
Biochem Biophys Rep. 2023 Jul 24;35:101519. doi: 10.1016/j.bbrep.2023.101519. eCollection 2023 Sep.
5
Circulating Biomarkers for Cancer Detection: Could Salivary microRNAs Be an Opportunity for Ovarian Cancer Diagnostics?用于癌症检测的循环生物标志物:唾液微小RNA能否成为卵巢癌诊断的契机?
Biomedicines. 2023 Feb 21;11(3):652. doi: 10.3390/biomedicines11030652.
6
Chitosan nanoparticle-mediated effect of antimiRNA-324-5p on decreasing the ovarian cancer cell proliferation by regulation of GLI1 expression.壳聚糖纳米颗粒介导的抗微小RNA-324-5p通过调控GLI1表达对降低卵巢癌细胞增殖的作用。
Bioimpacts. 2022;12(3):195-202. doi: 10.34172/bi.2021.22119. Epub 2021 Nov 29.
7
MicroRNAs: potential biomarkers for diagnosis and prognosis of different cancers.微小RNA:不同癌症诊断和预后的潜在生物标志物。
Transl Cancer Res. 2020 Sep;9(9):5798-5818. doi: 10.21037/tcr-20-1294.
8
Evaluation of circulating microRNAs as non-invasive biomarkers in the diagnosis of ovarian cancer: a case-control study.循环 microRNAs 作为卵巢癌无创性生物标志物的评估:病例对照研究。
Arch Gynecol Obstet. 2022 Jul;306(1):151-163. doi: 10.1007/s00404-021-06287-1. Epub 2021 Dec 10.
9
Characterizing Endocrine Status, Tumor Hypoxia and Immunogenicity for Therapy Success in Epithelial Ovarian Cancer.描述上皮性卵巢癌的内分泌状态、肿瘤缺氧和免疫原性,以预测治疗效果。
Front Endocrinol (Lausanne). 2021 Nov 17;12:772349. doi: 10.3389/fendo.2021.772349. eCollection 2021.
10
Impact of circulating miRNA-373 on breast cancer diagnosis through targeting VEGF and cyclin D1 genes.循环miRNA-373通过靶向血管内皮生长因子(VEGF)和细胞周期蛋白D1基因对乳腺癌诊断的影响。
J Genet Eng Biotechnol. 2021 Jun 5;19(1):84. doi: 10.1186/s43141-021-00174-7.

本文引用的文献

1
Mammalian miRNA RISC recruits CAF1 and PABP to affect PABP-dependent deadenylation.哺乳动物微小RNA诱导沉默复合体招募CAF1和多聚腺苷酸结合蛋白以影响多聚腺苷酸结合蛋白依赖性去腺苷酸化。
Mol Cell. 2009 Sep 24;35(6):868-80. doi: 10.1016/j.molcel.2009.08.004. Epub 2009 Aug 27.
2
Fertility preservation in young women with epithelial ovarian cancer.上皮性卵巢癌年轻女性的生育力保存
Cancer. 2009 Sep 15;115(18):4118-26. doi: 10.1002/cncr.24461.
3
MicroRNA reexpression as differentiation therapy in cancer.微小RNA重新表达作为癌症的分化疗法
J Clin Invest. 2009 Aug;119(8):2119-23. doi: 10.1172/JCI40107. Epub 2009 Jul 20.
4
Exploiting and antagonizing microRNA regulation for therapeutic and experimental applications.利用和拮抗微小RNA调控以用于治疗和实验应用。
Nat Rev Genet. 2009 Aug;10(8):578-85. doi: 10.1038/nrg2628.
5
Detection of cancer with serum miRNAs on an oligonucleotide microarray.利用寡核苷酸微阵列通过血清微小RNA检测癌症
PLoS One. 2009 Jul 14;4(7):e6229. doi: 10.1371/journal.pone.0006229.
6
Human microRNA target analysis and gene ontology clustering by GOmir, a novel stand-alone application.通过新型独立应用程序GOmir进行人类微小RNA靶标分析和基因本体聚类。
BMC Bioinformatics. 2009 Jun 16;10 Suppl 6(Suppl 6):S20. doi: 10.1186/1471-2105-10-S6-S20.
7
A pleiotropically acting microRNA, miR-31, inhibits breast cancer metastasis.一种具有多效性作用的微小RNA,即miR-31,可抑制乳腺癌转移。
Cell. 2009 Jun 12;137(6):1032-46. doi: 10.1016/j.cell.2009.03.047.
8
A miR-200 microRNA cluster as prognostic marker in advanced ovarian cancer.一种作为晚期卵巢癌预后标志物的miR-200微小RNA簇
Gynecol Oncol. 2009 Sep;114(3):457-64. doi: 10.1016/j.ygyno.2009.05.022. Epub 2009 Jun 5.
9
Labeled microRNA pull-down assay system: an experimental approach for high-throughput identification of microRNA-target mRNAs.标记的微小RNA下拉检测系统:一种用于高通量鉴定微小RNA靶标mRNA的实验方法。
Nucleic Acids Res. 2009 Jun;37(10):e77. doi: 10.1093/nar/gkp274. Epub 2009 May 6.
10
DIANA-microT web server: elucidating microRNA functions through target prediction.DIANA-microT网络服务器:通过靶标预测阐明微小RNA的功能
Nucleic Acids Res. 2009 Jul;37(Web Server issue):W273-6. doi: 10.1093/nar/gkp292. Epub 2009 Apr 30.